Bidyutprava Rout
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bidyutprava Rout has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Birasen Behera
SOA: Siksha O Anusandhan University, IMS and SUM Hospital, SOA Deemed TO BE University
7 shared publications - Sarita Otta
Department of Microbiology, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India
4 shared publications Ira Praharaj
Scientist-E, RMRC (ICMR), Bhubaneswar, Odisha, India
3 shared publications- Kundan Kumar Sahu
SOA: Siksha O Anusandhan University, IMS and SUM Hospital , SOA DEEMED TO BE UNIVERSITY
3 shared publications - Rajashree Panigrahy
Department of Microbiology, SUM Hospital, Bhubaneswar, Odisha, India
3 shared publications - Sumesh Kumar Dash
SOA: Siksha O Anusandhan University, IMS and SUM Hospital, SOA Deemed TO BE University
3 shared publications
Latest Publications
- Open Access
- 17 November 2025
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 24 (1) , 64
Genomic insights into novel ST7947 carbapenem-resistant hypervirulent Klebsiella pneumoniae: a threat from an Indian hospital setting
The rise of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKp) strains represents a major clinical threat, particularly in Asia. These strains possess both extensive drug resistance and enhanced virulence traits, leading to high morbidity and mortality. This study aimed to characterize the genomic profile of a CR-hvKp isolate (BB-7) obtained from a clinical case in eastern India and to investigate its resistance and virulence mechanisms. K. pneumoniae BB-7 was obtained from the urine sample of a 75-year-old male and identified by using the VITEK2 system and ITS–PCR amplification. Hypervirulence was confirmed through the string test and detection of the iucA gene. The antimicrobial susceptibility (AST) was determined by the Kirby-Bauer disk diffusion method, whereas colistin susceptibility was measured using broth microdilution. Whole-genome sequencing was performed using Illumina NovaSeq, followed by de novo assembly, annotation, and resistome/virulome analysis using tools including PROKKA, CARD, ResFinder, and VFAnalyzer. MLST, plasmid typing, capsular serotyping, phage element, and insertion element were analyzed by using an online database. Phylogenetic analysis was performed using cgMLST and core SNP approaches. BB-7 exhibited an extensively drug-resistant (XDR) phenotype, including resistance to β-lactams, fluoroquinolones, aminoglycosides, tetracyclines, and colistin. Resistance genes identified included blaCTX-M-15, blaSHV-28, blaTEM-1, blaOXA-232, blaOXA-1, armA, aadA2, and others. The virulence profile revealed genes such as iucABCD, iutA, iroEN, and T6SS clusters. Plasmid analysis identified IncHI1B, ColKP3, and IncFIB(K), contributing to the convergence of resistance and virulence. The Capsular serotype at K-locus and O-locus is K64 and O2α.1, respectively. The isolate was assigned a novel sequence type, ST7947 (gapA-1, infB-6, mdh-1, pgi-1, phoE-749, rpoB-46, tonB-1), differing from ST2096 by one allele phoE. Phylogenetic analysis revealed that BB-7 was closely related to ST2096 MDR K. pneumoniae isolates from an Indian hospital. BB-7 represents a novel CR-hvKp strain with a unique ST7947 genotype, exhibiting co-resistance and hypervirulence, raising concern for public health. The association of high-risk resistance plasmids with virulence factors underscores the urgent need for enhanced genomic surveillance, infection control, and devising specific therapies to restrict the proliferation of such strains.
- 17 November 2025
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 24 (1) , 64
Open AccessGenomic insights into novel ST7947 carbapenem-resistant hypervirulent Klebsiella pneumoniae: a threat from an Indian hospital setting
The rise of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKp) strains represents a major clinical threat, particularly in Asia. These strains possess both extensive drug resistance and enhanced virulence traits, leading to high morbidity and mortality. This study aimed to characterize the genomic profile of a CR-hvKp isolate (BB-7) obtained from a clinical case in eastern India and to investigate its resistance and virulence mechanisms. K. pneumoniae BB-7 was obtained from the urine sample of a 75-year-old male and identified by using the VITEK2 system and ITS–PCR amplification. Hypervirulence was confirmed through the string test and detection of the iucA gene. The antimicrobial susceptibility (AST) was determined by the Kirby-Bauer disk diffusion method, whereas colistin susceptibility was measured using broth microdilution. Whole-genome sequencing was performed using Illumina NovaSeq, followed by de novo assembly, annotation, and resistome/virulome analysis using tools including PROKKA, CARD, ResFinder, and VFAnalyzer. MLST, plasmid typing, capsular serotyping, phage element, and insertion element were analyzed by using an online database. Phylogenetic analysis was performed using cgMLST and core SNP approaches. BB-7 exhibited an extensively drug-resistant (XDR) phenotype, including resistance to β-lactams, fluoroquinolones, aminoglycosides, tetracyclines, and colistin. Resistance genes identified included blaCTX-M-15, blaSHV-28, blaTEM-1, blaOXA-232, blaOXA-1, armA, aadA2, and others. The virulence profile revealed genes such as iucABCD, iutA, iroEN, and T6SS clusters. Plasmid analysis identified IncHI1B, ColKP3, and IncFIB(K), contributing to the convergence of resistance and virulence. The Capsular serotype at K-locus and O-locus is K64 and O2α.1, respectively. The isolate was assigned a novel sequence type, ST7947 (gapA-1, infB-6, mdh-1, pgi-1, phoE-749, rpoB-46, tonB-1), differing from ST2096 by one allele phoE. Phylogenetic analysis revealed that BB-7 was closely related to ST2096 MDR K. pneumoniae isolates from an Indian hospital. BB-7 represents a novel CR-hvKp strain with a unique ST7947 genotype, exhibiting co-resistance and hypervirulence, raising concern for public health. The association of high-risk resistance plasmids with virulence factors underscores the urgent need for enhanced genomic surveillance, infection control, and devising specific therapies to restrict the proliferation of such strains.
- 24 February 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-10
Colistin resistance in carbapenem non-susceptible Acinetobacter baumanii in a tertiary care hospital in India: clinical characteristics, antibiotic susceptibility and molecular characterization
Introduction Acinetobacter baumanii (AB) is a bacterium of concern in the hospital setup due to its ability to thrive in unfavorable conditions and the rapid emergence of antibiotic resistance. Carbapenem resistance in this organism is disheartening, further clouded by the emergence of colistin resistance. Aim The present prospective study aims to note the epidemiology, molecular profile, and clinical outcome of patients with colistin resistance AB infections in a multispecialty tertiary care setup in Odisha, Eastern India. Methods All AB strains received from March 2021 to February 2022, identified by Vitek2 (Biomerieux) and confirmed by oxa-51 genes, were included. Carbapenem and colistin resistance were identified as per CLSI guidelines. Known mutations for blaOXA-23-like, blaIMP, blaVIM, blaKP, lpxA, lpxC, pmrA, pmrB, and plasmid mediated mcr (mcr1-5) were screened by conventional PCR techniques. The clinical outcome was noted retrospectively from case sheets. Data was entered in MS Excel and tabulated using SPSS software. Results In the study period, 350 AB were obtained, of which 317(90.5%) were carbapenem resistant (CRAB). Among the CRAB isolates, 19 (5.9%) were colistin resistant (ABCoR). The most valuable antibiotics in the study were tigecycline (65.4% in ABCoI; 31.6% in ABCoR) and minocycline (44.3% in CI; 36.8% in CR). There was a significant difference in mortality among ABCoI and ABCoR infections. bla OXA was the predominant carbapenem resistance genotype, while pmrA was the predominant colistin resistant genotype. There were no plasmid mediated mcr genes detected in the present study.
- 24 February 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-10
Colistin resistance in carbapenem non-susceptible Acinetobacter baumanii in a tertiary care hospital in India: clinical characteristics, antibiotic susceptibility and molecular characterization
Introduction Acinetobacter baumanii (AB) is a bacterium of concern in the hospital setup due to its ability to thrive in unfavorable conditions and the rapid emergence of antibiotic resistance. Carbapenem resistance in this organism is disheartening, further clouded by the emergence of colistin resistance. Aim The present prospective study aims to note the epidemiology, molecular profile, and clinical outcome of patients with colistin resistance AB infections in a multispecialty tertiary care setup in Odisha, Eastern India. Methods All AB strains received from March 2021 to February 2022, identified by Vitek2 (Biomerieux) and confirmed by oxa-51 genes, were included. Carbapenem and colistin resistance were identified as per CLSI guidelines. Known mutations for blaOXA-23-like, blaIMP, blaVIM, blaKP, lpxA, lpxC, pmrA, pmrB, and plasmid mediated mcr (mcr1-5) were screened by conventional PCR techniques. The clinical outcome was noted retrospectively from case sheets. Data was entered in MS Excel and tabulated using SPSS software. Results In the study period, 350 AB were obtained, of which 317(90.5%) were carbapenem resistant (CRAB). Among the CRAB isolates, 19 (5.9%) were colistin resistant (ABCoR). The most valuable antibiotics in the study were tigecycline (65.4% in ABCoI; 31.6% in ABCoR) and minocycline (44.3% in CI; 36.8% in CR). There was a significant difference in mortality among ABCoI and ABCoR infections. bla OXA was the predominant carbapenem resistance genotype, while pmrA was the predominant colistin resistant genotype. There were no plasmid mediated mcr genes detected in the present study.
- 22 January 2024
- Published by Springer Nature in International Microbiology
- Vol. 27 (5) , 1373-1382
Genotypic characterization of hypervirulent Klebsiella pneumoniae (hvKp) in a tertiary care Indian hospital
Hypervirulent Klebsiella pneumoniae (hvKp) is an emerging pathogen and causes endophthalmitis, liver abscess, osteomyelitis, meningitis, and necrotizing soft tissue infections in both immunodeficient and healthy people. The acquisition of the antibiotic resistance genes of hvKp has become an emerging concern throughout the globe. In this study, a total of 74 K. pneumoniae isolates were collected and identified by VITEK2 and blaSHV gene amplification. Out of these, 18.91% (14/74) isolates were identified as hvKp by both phenotypic string test and genotypic iucA PCR amplification. The antibiotic susceptibility revealed that 57.14% (8/14) isolates were multidrug-resistant (MDR) and 35.71% (5/14) isolates were extremely drug-resistant (XDR). All the isolates were resistant to β-lactam, β-lactamase + inhibitor groups of antibiotics, and the least resistance to colistin. Of 14 hvKp isolates, all isolates are positive for iroB (100%), followed by iutA (92.85%), peg344 (85.71%), rmpA (57.14%), and magA (21.42%) genes. Among serotypes, K1 was the most prevalent serotype 21.4% (3/14), followed by K5 14.3% (2/14). The most common carbapenemase gene was blaOXA-48 (78.57%) followed by blaNDM (14.28%) and blaKPC (14.28%) which co-carried multiple resistance genes such as blaSHV (100%), blaCTX-M (92.85%), and blaTEM (78.57%). About 92.85% (13/14) of hvKp isolates were strong biofilm producers, while one isolate (hvKp 10) was the only moderate biofilm producer. The (GTG)5-PCR molecular typing method revealed high diversity among the hvKp isolates in the tertiary care hospital. Our findings suggest that MDR-hvKp is an emerging pathogen and a challenge for clinical practice. In order to avoid hvKp strain outbreaks in hospital settings, robust infection control and effective surveillance should be implemented.
- 22 January 2024
- Published by Springer Nature in International Microbiology
- Vol. 27 (5) , 1373-1382
Genotypic characterization of hypervirulent Klebsiella pneumoniae (hvKp) in a tertiary care Indian hospital
Hypervirulent Klebsiella pneumoniae (hvKp) is an emerging pathogen and causes endophthalmitis, liver abscess, osteomyelitis, meningitis, and necrotizing soft tissue infections in both immunodeficient and healthy people. The acquisition of the antibiotic resistance genes of hvKp has become an emerging concern throughout the globe. In this study, a total of 74 K. pneumoniae isolates were collected and identified by VITEK2 and blaSHV gene amplification. Out of these, 18.91% (14/74) isolates were identified as hvKp by both phenotypic string test and genotypic iucA PCR amplification. The antibiotic susceptibility revealed that 57.14% (8/14) isolates were multidrug-resistant (MDR) and 35.71% (5/14) isolates were extremely drug-resistant (XDR). All the isolates were resistant to β-lactam, β-lactamase + inhibitor groups of antibiotics, and the least resistance to colistin. Of 14 hvKp isolates, all isolates are positive for iroB (100%), followed by iutA (92.85%), peg344 (85.71%), rmpA (57.14%), and magA (21.42%) genes. Among serotypes, K1 was the most prevalent serotype 21.4% (3/14), followed by K5 14.3% (2/14). The most common carbapenemase gene was blaOXA-48 (78.57%) followed by blaNDM (14.28%) and blaKPC (14.28%) which co-carried multiple resistance genes such as blaSHV (100%), blaCTX-M (92.85%), and blaTEM (78.57%). About 92.85% (13/14) of hvKp isolates were strong biofilm producers, while one isolate (hvKp 10) was the only moderate biofilm producer. The (GTG)5-PCR molecular typing method revealed high diversity among the hvKp isolates in the tertiary care hospital. Our findings suggest that MDR-hvKp is an emerging pathogen and a challenge for clinical practice. In order to avoid hvKp strain outbreaks in hospital settings, robust infection control and effective surveillance should be implemented.
- Open Access
- 1 October 2023
- Published by Microbiology Society in Access Microbiology
- Vol. 5 (10) , 000595.v3
Evaluation of different methods for in vitro susceptibility testing of colistin in carbapenem resistant Gram-negative bacilli
Introduction. The increasing antibiotic resistance like the advent of carbapenem resistant Enterobactarales (CRE), Carbapenem Resistant Acinetobacter baumanii (CRAB), and Carbapenem Resistant Pseudomonas aeruginosa (CRPA) has led to to the use of toxic and older drugs like colistin for these organisms. But worldwide there is an increase in resistance even to colistin mediated both by chromosomes and plasmids. This necessitates accurate detection of resistance. This is impeded by the unavailability of a user-friendly phenotypic methods for use in routine clinical microbiology practice. The present study attempts to evaluate two different methods – colistin broth disc elution and MIC detection by Vitek two in comparison to CLSI approved broth microdilution (BMD) for colistin for Enterobactarales, Pseudomonas aeruginosa , and Acinetobacter baumanii clinical isolates. Methods. Colistin susceptibility of 6013 carbapenem resistant isolates was determined by BMD, Colistin Broth Disc Elution (CBDE), and Vitek two methods and was interpreted as per CLSI guidelines. The MIC results of CBDE, Vitek two were compared with that of BMD and essential agreement (EA), categorical agreement (CA), sensitivity, specificity, very major error (VME), major error (ME) and Cohen’s kappa (CK) was calculated. The presence of any plasmid-mediated colistin resistance (mcr-1, 2, 3, 4 and 5) was evaluated in all colistin-resistant isolates by conventional polymerase chain reaction. Results. Colistin resistance was found in 778 (12.9 %) strains among the carbapenem resistant isolates. Klebsiella pneumoniae had the highest (18.9 %) colistin resistance by the BMD method. MIC of Vitek two had sensitivity ranging from 78.2–84.8% and specificity of >92 %. There were 171 VMEs and 323 MEs by Vitek two method, much more than CLSI acceptable range. The highest percentage of errors was committed for Acinetobacter baumanii (27.8 % of VME and 7.9 % ME). On the other hand, the CBDE method performed well with EA, CA, VME and ME within acceptable range for all the organisms. The sensitivity of the CBDE method compared to gold standard BMD varied from 97.5–98.8 % for different strains with a specificity of more than 97.6 %. None of the isolated colistin resistant organisms harboured mcr plasmids. Conclusion. As BMD has many technical complexities, CBDE is the best viable alternative available for countries like India. A sensitive MIC reported by Vitek two needs to be carefully considered due high propensity for VMEs particularly for Klebsiella spp.
- 1 October 2023
- Published by Microbiology Society in Access Microbiology
- Vol. 5 (10) , 000595.v3
Open AccessEvaluation of different methods for in vitro susceptibility testing of colistin in carbapenem resistant Gram-negative bacilli
Introduction. The increasing antibiotic resistance like the advent of carbapenem resistant Enterobactarales (CRE), Carbapenem Resistant Acinetobacter baumanii (CRAB), and Carbapenem Resistant Pseudomonas aeruginosa (CRPA) has led to to the use of toxic and older drugs like colistin for these organisms. But worldwide there is an increase in resistance even to colistin mediated both by chromosomes and plasmids. This necessitates accurate detection of resistance. This is impeded by the unavailability of a user-friendly phenotypic methods for use in routine clinical microbiology practice. The present study attempts to evaluate two different methods – colistin broth disc elution and MIC detection by Vitek two in comparison to CLSI approved broth microdilution (BMD) for colistin for Enterobactarales, Pseudomonas aeruginosa , and Acinetobacter baumanii clinical isolates. Methods. Colistin susceptibility of 6013 carbapenem resistant isolates was determined by BMD, Colistin Broth Disc Elution (CBDE), and Vitek two methods and was interpreted as per CLSI guidelines. The MIC results of CBDE, Vitek two were compared with that of BMD and essential agreement (EA), categorical agreement (CA), sensitivity, specificity, very major error (VME), major error (ME) and Cohen’s kappa (CK) was calculated. The presence of any plasmid-mediated colistin resistance (mcr-1, 2, 3, 4 and 5) was evaluated in all colistin-resistant isolates by conventional polymerase chain reaction. Results. Colistin resistance was found in 778 (12.9 %) strains among the carbapenem resistant isolates. Klebsiella pneumoniae had the highest (18.9 %) colistin resistance by the BMD method. MIC of Vitek two had sensitivity ranging from 78.2–84.8% and specificity of >92 %. There were 171 VMEs and 323 MEs by Vitek two method, much more than CLSI acceptable range. The highest percentage of errors was committed for Acinetobacter baumanii (27.8 % of VME and 7.9 % ME). On the other hand, the CBDE method performed well with EA, CA, VME and ME within acceptable range for all the organisms. The sensitivity of the CBDE method compared to gold standard BMD varied from 97.5–98.8 % for different strains with a specificity of more than 97.6 %. None of the isolated colistin resistant organisms harboured mcr plasmids. Conclusion. As BMD has many technical complexities, CBDE is the best viable alternative available for countries like India. A sensitive MIC reported by Vitek two needs to be carefully considered due high propensity for VMEs particularly for Klebsiella spp.
- Open Access
- 23 August 2023
- Published by Microbiology Society
- p. 000595.v2
Evaluation of different methods for in vitro susceptibility testing of colistin in carbapenem resistant Gram negative bacilli
Introduction- The increasing antibiotic resistance like advent of carbapenem resistant Enterobactarales (CRE), Carbapenem Resistant Acinetobacter baumanii (CRAB) and Carbapenem Resistant Pseudomonas aeruginosa (CRPA) has led to use of toxic and older drugs like colistin for these organisms. But worldwide there is an increase in resistance even to colistin mediated both by chromosomes and plasmids. This necessitates accurate detection of resistance. This is impeded by unavailability of a user friendly phenotypic method for use in routine clinical microbiology practice. The present study attempts to evaluate two different methods- Colistin broth disc elution and MIC detection by Vitek 2 in comparison to CLSI approved broth microdilution (BMD) for colistin for Enterobactarales, Pseudomonas aeruginosa and Acinetobacter baumanii clinical isolates. Methods- Colistin susceptibility of 6013 carbapenem resistant isolates was determined by BMD, Colistin Broth Disc Elution (CBDE) and Vitek2 methods and was interpreted as per CLSI guidelines. The MIC results of CBDE, Vitek 2 were compared with that of BMD and essential agreement (EA), categorical agreement (CA), sensitivity, specificity, very major error (VME), major error (ME) and cohen’s kappa (CK) was calculated. Presence of any plasmid-mediated colistin resistance (mcr-1, 2, 3, 4 and 5) was evaluated all colistin resistant isolates by conventional polymerase chain reaction. Results- Colistin resistance was found in 778 (12.9%) strains among the carbapenem resistant isolates. Klebsiella pneumoniae had the highest (18.9%) colistin resistance by BMD method. MIC of Vitek 2 had sensitivity ranging from 78.2% to 84.8% and specificity of > 92%. There were 171 VMEs and 323 MEs by Vitek2 method, much more than CLSI acceptable range. The highest percentage of errors was committed for Acinetobacter baumanii (27.8% of VME and 7.9% ME). On the other hand the CBDE method performed well with EA, CA, VME and ME within acceptable range for all the organisms. The sensitivity of CBDE method compared to gold standard BMD varied from 97.5%-98.8% for different strains with a specificity of more than 97.6%. None of the isolated colistin resistant organism harbored mcr plasmids. Conclusion- As BMD has many technical complexities, CBDE is the best viable alternative available for countries like India. A sensitive MIC reported by Vitek2 needs to be carefully considered due high propensity for VMEs particularly for Klebsiella spp. Data summary- Supplementary material provides data regarding the comparison of MICs of three different mmethods for all samples. Sheet 1 to Sheet 5 contains data for E.coli, K.pneumoniae,A.baumannii, P.aeruginosa, E. cloacae respectively.
- 23 August 2023
- Published by Microbiology Society
- p. 000595.v2
Open AccessEvaluation of different methods for in vitro susceptibility testing of colistin in carbapenem resistant Gram negative bacilli
Introduction- The increasing antibiotic resistance like advent of carbapenem resistant Enterobactarales (CRE), Carbapenem Resistant Acinetobacter baumanii (CRAB) and Carbapenem Resistant Pseudomonas aeruginosa (CRPA) has led to use of toxic and older drugs like colistin for these organisms. But worldwide there is an increase in resistance even to colistin mediated both by chromosomes and plasmids. This necessitates accurate detection of resistance. This is impeded by unavailability of a user friendly phenotypic method for use in routine clinical microbiology practice. The present study attempts to evaluate two different methods- Colistin broth disc elution and MIC detection by Vitek 2 in comparison to CLSI approved broth microdilution (BMD) for colistin for Enterobactarales, Pseudomonas aeruginosa and Acinetobacter baumanii clinical isolates. Methods- Colistin susceptibility of 6013 carbapenem resistant isolates was determined by BMD, Colistin Broth Disc Elution (CBDE) and Vitek2 methods and was interpreted as per CLSI guidelines. The MIC results of CBDE, Vitek 2 were compared with that of BMD and essential agreement (EA), categorical agreement (CA), sensitivity, specificity, very major error (VME), major error (ME) and cohen’s kappa (CK) was calculated. Presence of any plasmid-mediated colistin resistance (mcr-1, 2, 3, 4 and 5) was evaluated all colistin resistant isolates by conventional polymerase chain reaction. Results- Colistin resistance was found in 778 (12.9%) strains among the carbapenem resistant isolates. Klebsiella pneumoniae had the highest (18.9%) colistin resistance by BMD method. MIC of Vitek 2 had sensitivity ranging from 78.2% to 84.8% and specificity of > 92%. There were 171 VMEs and 323 MEs by Vitek2 method, much more than CLSI acceptable range. The highest percentage of errors was committed for Acinetobacter baumanii (27.8% of VME and 7.9% ME). On the other hand the CBDE method performed well with EA, CA, VME and ME within acceptable range for all the organisms. The sensitivity of CBDE method compared to gold standard BMD varied from 97.5%-98.8% for different strains with a specificity of more than 97.6%. None of the isolated colistin resistant organism harbored mcr plasmids. Conclusion- As BMD has many technical complexities, CBDE is the best viable alternative available for countries like India. A sensitive MIC reported by Vitek2 needs to be carefully considered due high propensity for VMEs particularly for Klebsiella spp. Data summary- Supplementary material provides data regarding the comparison of MICs of three different mmethods for all samples. Sheet 1 to Sheet 5 contains data for E.coli, K.pneumoniae,A.baumannii, P.aeruginosa, E. cloacae respectively.
- Open Access
- 16 March 2023
- Published by Microbiology Society
- p. 000595.v1
Evaluation of different methods for in vitro susceptibility testing of colistin in carbapenem resistant Gram negative bacilli
Introduction- The increasing antibiotic resistance like advent of carbapenem resistant Enterobactarales (CRE), Carbapenem Resistant Acinetobacter baumanii (CRAB) and Carbapenem Resistant Pseudomonas aeruginosa (CRPA) has led to use of toxic and older drugs like colistin for these organisms. But worldwide there is an increase in resistance even to colistin mediated both by chromosomes and plasmids. This necessitates accurate detection of resistance. This is impeded by unavailability of a user friendly phenotypic method for use in routine clinical microbiology practice. The present study attempts to evaluate two different methods- Colistin broth disc elution and MIC detection by Vitek 2 in comparison to CLSI approved broth microdilution (BMD) for colistin for Enterobactarales, Pseudomonas aeruginosa and Acinetobacter baumanii clinical isolates. Methods- Colistin susceptibility of 6013 carbapenem resistant isolates was determined by BMD, Colistin Broth Disc Elution (CBDE) and Vitek2 methods and was interpreted as per CLSI guidelines. The MIC results of CBDE, Vitek 2 were compared with that of BMD and essential agreement (EA), categorical agreement (CA), sensitivity, specificity, very major error (VME), major error (ME) and cohen’s kappa (CK) was calculated. Presence of any plasmid-mediated colistin resistance (mcr-1, 2, 3, 4 and 5) was evaluated all colistin resistant isolates by conventional polymerase chain reaction. Results- Colistin resistance was found in 778 (12.9%) strains among the carbapenem resistant isolates. Klebsiella pneumoniae had the highest (18.9%) colistin resistance by BMD method. MIC of Vitek 2 had sensitivity ranging from 78.2% to 84.8% and specificity of > 92%. There were 171 VMEs and 323 MEs by Vitek2 method, much more than CLSI acceptable range. The highest percentage of errors was committed for Acinetobacter baumanii (27.8% of VME and 7.9% ME). On the other hand the CBDE method performed well with EA, CA, VME and ME within acceptable range for all the organisms. The sensitivity of CBDE method compared to gold standard BMD varied from 97.5%-98.8% for different strains with a specificity of more than 97.6%. None of the isolated colistin resistant organism harbored mcr plasmids. Conclusion- As BMD has many technical complexities, CBDE is the best viable alternative available for countries like India. A sensitive MIC reported by Vitek2 needs to be carefully considered due high propensity for VMEs particularly for Klebsiella spp. Data summary- Supplementary material provides data regarding the comparison of MICs of three different mmethods for all samples. Sheet 1 to Sheet 5 contains data for E.coli, K.pneumoniae, A.baumannii, P.aeruginosa, E. cloacae respectively.
- 16 March 2023
- Published by Microbiology Society
- p. 000595.v1
Open AccessEvaluation of different methods for in vitro susceptibility testing of colistin in carbapenem resistant Gram negative bacilli
Introduction- The increasing antibiotic resistance like advent of carbapenem resistant Enterobactarales (CRE), Carbapenem Resistant Acinetobacter baumanii (CRAB) and Carbapenem Resistant Pseudomonas aeruginosa (CRPA) has led to use of toxic and older drugs like colistin for these organisms. But worldwide there is an increase in resistance even to colistin mediated both by chromosomes and plasmids. This necessitates accurate detection of resistance. This is impeded by unavailability of a user friendly phenotypic method for use in routine clinical microbiology practice. The present study attempts to evaluate two different methods- Colistin broth disc elution and MIC detection by Vitek 2 in comparison to CLSI approved broth microdilution (BMD) for colistin for Enterobactarales, Pseudomonas aeruginosa and Acinetobacter baumanii clinical isolates. Methods- Colistin susceptibility of 6013 carbapenem resistant isolates was determined by BMD, Colistin Broth Disc Elution (CBDE) and Vitek2 methods and was interpreted as per CLSI guidelines. The MIC results of CBDE, Vitek 2 were compared with that of BMD and essential agreement (EA), categorical agreement (CA), sensitivity, specificity, very major error (VME), major error (ME) and cohen’s kappa (CK) was calculated. Presence of any plasmid-mediated colistin resistance (mcr-1, 2, 3, 4 and 5) was evaluated all colistin resistant isolates by conventional polymerase chain reaction. Results- Colistin resistance was found in 778 (12.9%) strains among the carbapenem resistant isolates. Klebsiella pneumoniae had the highest (18.9%) colistin resistance by BMD method. MIC of Vitek 2 had sensitivity ranging from 78.2% to 84.8% and specificity of > 92%. There were 171 VMEs and 323 MEs by Vitek2 method, much more than CLSI acceptable range. The highest percentage of errors was committed for Acinetobacter baumanii (27.8% of VME and 7.9% ME). On the other hand the CBDE method performed well with EA, CA, VME and ME within acceptable range for all the organisms. The sensitivity of CBDE method compared to gold standard BMD varied from 97.5%-98.8% for different strains with a specificity of more than 97.6%. None of the isolated colistin resistant organism harbored mcr plasmids. Conclusion- As BMD has many technical complexities, CBDE is the best viable alternative available for countries like India. A sensitive MIC reported by Vitek2 needs to be carefully considered due high propensity for VMEs particularly for Klebsiella spp. Data summary- Supplementary material provides data regarding the comparison of MICs of three different mmethods for all samples. Sheet 1 to Sheet 5 contains data for E.coli, K.pneumoniae, A.baumannii, P.aeruginosa, E. cloacae respectively.
- Open Access
- 7 July 2022
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 16 (3) , 1682-1688
Prevalence of ESBL Producing Bacteria in Community-Acquired UTI from Eastern Part of India
Urinary tract infection (UTI) in the community is a common infection in humans. The causative microorganisms for UTIs may vary in different places and also vary in their antibiotic sensitivity and resistant patterns. This study aimed to find out the incidence of gram-negative bacteria along with their antibiotic sensitivity pattern in community-acquired UTIs and to calculate the existence of Extended-spectrum beta-lactamase (ESBL) positivity among them. A Sum of 515 urine samples was tested and the causative organisms were identified. Antibiotic susceptibility tests were executed where it had shown growth for bacteria by both manual and automated methods. ESBL tests were performed to identify ESBL-producing isolates. From a total of 515 samples, 65 (12.65%) were culture positive for UTIs. The rate of infection was higher in females than in males. The most prevailing bacteria were Escherichia coli and Klebsiella pneumoniae. Out of total culture-positive isolates, only 43.08% were ESBL positives. The study found that the organisms displayed resistance to Ciprofloxacin and Cefixime and sensitivity to Gentamicin, Ertapenem, and Nitrofurantoin. Females have a higher prevalence of UTIs than males. Mostly, females suffer from UTIs in their reproductive years whereas males suffer in their old age. The prevalence of gram-negative bacteria is higher in community-acquired UTIs. These pathogens though present in the community, becoming resistant to commonly used antibiotics like Ciprofloxacin and Cefixime because of overuse and misuse of antibiotics at the community level.
- 7 July 2022
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 16 (3) , 1682-1688
Open AccessPrevalence of ESBL Producing Bacteria in Community-Acquired UTI from Eastern Part of India
Urinary tract infection (UTI) in the community is a common infection in humans. The causative microorganisms for UTIs may vary in different places and also vary in their antibiotic sensitivity and resistant patterns. This study aimed to find out the incidence of gram-negative bacteria along with their antibiotic sensitivity pattern in community-acquired UTIs and to calculate the existence of Extended-spectrum beta-lactamase (ESBL) positivity among them. A Sum of 515 urine samples was tested and the causative organisms were identified. Antibiotic susceptibility tests were executed where it had shown growth for bacteria by both manual and automated methods. ESBL tests were performed to identify ESBL-producing isolates. From a total of 515 samples, 65 (12.65%) were culture positive for UTIs. The rate of infection was higher in females than in males. The most prevailing bacteria were Escherichia coli and Klebsiella pneumoniae. Out of total culture-positive isolates, only 43.08% were ESBL positives. The study found that the organisms displayed resistance to Ciprofloxacin and Cefixime and sensitivity to Gentamicin, Ertapenem, and Nitrofurantoin. Females have a higher prevalence of UTIs than males. Mostly, females suffer from UTIs in their reproductive years whereas males suffer in their old age. The prevalence of gram-negative bacteria is higher in community-acquired UTIs. These pathogens though present in the community, becoming resistant to commonly used antibiotics like Ciprofloxacin and Cefixime because of overuse and misuse of antibiotics at the community level.